Matthew K Fust is of Ultragenyx Pharmaceutical Inc.. Currently has a direct ownership of 20,205 shares of RARE, which is worth approximately $893,465. The most recent transaction as insider was on Jun 18, 2024, when has been sold 5,345 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 20.2K
0% 3M change
25.32% 12M change
Total Value Held $893,465

Matthew K Fust Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 18 2024
BUY
Grant, award, or other acquisition
-
5,345 Added 20.92%
20,205 Common Stock
Mar 07 2024
SELL
Open market or private sale
$620,359 $50.87 p/Share
12,195 Reduced 45.07%
14,860 Common Stock
Jun 07 2023
SELL
Sale (or disposition) back to the issuer
$171,006 $51.82 p/Share
3,300 Reduced 10.87%
27,055 Common Stock
Jun 07 2023
BUY
Grant, award, or other acquisition
-
3,860 Added 11.28%
30,355 Common Stock
Jun 24 2022
BUY
Grant, award, or other acquisition
-
3,300 Added 11.08%
26,495 Common Stock
Mar 04 2022
BUY
Exercise of conversion of derivative security
$302,775 $40.37 p/Share
7,500 Added 24.43%
23,195 Common Stock
Jun 24 2021
BUY
Grant, award, or other acquisition
-
2,145 Added 12.02%
15,695 Common Stock

Also insider at

CRNX
Crinetics Pharmaceuticals, Inc. Healthcare
ATRA
Atara Biotherapeutics, Inc. Healthcare
NMRA
Neumora Therapeutics, Inc.
MKF

Matthew K Fust

San Diego, CA

Track Institutional and Insider Activities on RARE

Follow Ultragenyx Pharmaceutical Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RARE shares.

Notify only if

Insider Trading

Get notified when an Ultragenyx Pharmaceutical Inc. insider buys or sells RARE shares.

Notify only if

News

Receive news related to Ultragenyx Pharmaceutical Inc.

Track Activities on RARE